Speaker Profile
M.D., Professor, Stanford
Biography
1988-1992, Dr. Weissman and colleagues isolated the firstblood-formingstem cells in mice and humans and successfully isolated humanLeukemiacancer stem cells in 2000. His laboratories also discovered thehuman HSC,a human brain-forming stem cell population, mouse skeletalmuscle stemcells, and an osteochondral stem cell in mice. His work anddiscoveries onstem cell aging contributed to the understanding of cancerstem cells andthe immune system and are pioneering achievements withfar-reachingclinical applications. Recently, Dr. Weissman and hiscolleaguesidentified a protein, CD47, that is highly expressed duringthe latestages of cancer stem cell progression and is currently beingstudied as apotential cancer therapeutic. Dr. Weissman, a proven leader inthe fieldof cancer stem cell biology, founded three companies focusedon bringingstem cell therapies into the clinic. He was also on thefoundingScientific Advisory boards of companies Amgen, DNAX, and T Cell Sciences.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Catriona Jamieson, UCSD
Opening talk
• Catriona Jamieson, UCSD
PMWC Award Ceremony
• Judy Faulkner, Epic
• Alexis C. Komor, UCSD
What’s Next at Epic?
• Peter DeVault, Epic
Modified mRNA, siRNA, ASOs
• Chair: Alexis C. Komor, UCSD
• Niren Murthy, UC Berkeley
• Gene Yeo, UCSD
• Reuben Harris, UT Health San Antonio
Stem Cell-Targeted Therapeutics: Small Molecules & Biologics
• Chair: Catriona Jamieson, UCSD
• Irving L. Weissman, Stanford
Space-Omics & Stem-Cell Adaptation
• Chair: Catriona Jamieson, UCSD
• Alysson Muotri, UCSD
In Vivo Gene Therapies
• Chair: Gene Yeo, UCSD
• Mark A Kay, Stanford
• David Schaffer, Berkeley
Diagnostics, Prognostics, and Patient Stratification
• Chair: Ezra Cohen, Tempus
• Eitan Ruppin, NIH
• David Ledbetter, Florida State University
• Ludmil Alexandrov, UCSD
Bioprinting Transplantable Liver: mRNA-Driven Multi-Lineage Differentiation from Autologous iPSCs
• Jiwu Wang, The Scintillon Institute
A New Era in Heart Failure Treatment: Delivering on the Promise of iPSC-Derived Cardiomyocyte Therapy
• Eugene Wang, Help Therapeutics
Closing Talk
• Catriona Jamieson, UCSD
